Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if sequential administration of
decitabine and clofarabine can help to control MDS better than decitabine alone. The safety
of this drug combination will also be studied.